Search by Drug Name or NDC

    NDC 55111-0784-01 Fexofenadine hydrochloride 180 mg/1 Details

    Fexofenadine hydrochloride 180 mg/1

    Fexofenadine hydrochloride is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is FEXOFENADINE HYDROCHLORIDE.

    Product Information

    NDC 55111-0784
    Product ID 55111-784_e637b622-72de-e0be-d4e8-c2fac4efc8da
    Associated GPIs 41550024100350
    GCN Sequence Number 033716
    GCN Sequence Number Description fexofenadine HCl TABLET 180 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 46594
    HICL Sequence Number 011595
    HICL Sequence Number Description FEXOFENADINE HCL
    Brand/Generic Generic
    Proprietary Name Fexofenadine hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fexofenadine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 180
    Active Ingredient Units mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076502
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0784-01 (55111078401)

    NDC Package Code 55111-784-01
    Billing NDC 55111078401
    Package 1 BOTTLE in 1 CARTON (55111-784-01) / 100 TABLET in 1 BOTTLE
    Marketing Start Date 2011-01-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.25711
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description FEXOFENADINE HCL 180 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis